Imidazopyrimidine-based pyruvate kinase M2 activator halts diabetic nephropathy progression via modulating epithelial-to-mesenchymal transition and fibrosis - Meenakshi Jain; Adil Ali Sayyed; Piyush Gondaliya; Saumya Kapoor; Deep Rohan Chatterjee; Rudradip Das; Kiran Kalia; Amit Khairnar; Amit Shard (Chemico-Biological Interactions, 2025)